ketamine hydrochloride · Ph Health · NDA 016812

Ketalar

Earliest generic entry, as listed · earliest of 3 marketed strengths
Open now

No unexpired patents or exclusivities are listed for this product.

Listed patents · 0 unexpired

No unexpired patents listed.

Exclusivities · 0 unexpired

No unexpired exclusivities listed.

Paragraph IV certifications · 0

No Paragraph IV certification listed by FDA for this drug.

The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.

Event history

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products covered · 3

NDA · productFormStrengthListed expiry
016812 · 001 · RLDinjectable, injectionEQ 10MG BASE/MLopen
016812 · 002 · RLDinjectable, injectionEQ 50MG BASE/MLopen
016812 · 003 · RLDinjectable, injectionEQ 100MG BASE/MLopen